Cost-effectiveness of leucocyte-depleted erythrocyte transfusion in cardiac valve surgery

Transfusion Medicine

Volumn 15, Issue 3, 2005, Pages 209-217

  Van Hulst, M ^a,b   Bilgin, Y M ^c   Van De Watering, L M G ^d,e   De Vries, R ^a   Van Oers, M H J ^c   Brand, A ^d,e   Postma, M J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b MARTINI HOSPITAL   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Sanquin Bloedbank Regio Zuidwest Rotterdam   (Netherlands)

Author keywords

Blood transfusion; Cost effectiveness analysis; Grafting; Surgery; Valves

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD FILTRATION; CORONARY ARTERY BYPASS GRAFT; COST EFFECTIVENESS ANALYSIS; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; HEALTH CARE COST; HEART VALVE SURGERY; HUMAN; LONGEVITY; MAJOR CLINICAL STUDY; MALE; MORTALITY;

AGED; COST-BENEFIT ANALYSIS; ERYTHROCYTE TRANSFUSION; FEMALE; HEART VALVES; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS;

EID: 20444504741     PISSN: 09587578     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2005.00573.x     Document Type: Article

References (28)

1. Anonymous. (1996) Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. The New England Journal of Medicine, 335, 217-225.
2. Al, M.J., Koopmanschap, M.A., van Enckevort, P.J., van der Geertsma, A., Bij, W., de Boer, W.J. & Ten Vergert, E.M. (1998) Cost-effectiveness of lung transplantation in The Netherlands: a scenario analysis. Chest, 113, 124-130.
3. AuBuchon, J.P., Birkmeyer, J.D. & Busch, M.P. (1997) Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood. Transfusion, 37, 45-51.
4. Balducci, L., Benson, K., Lyman, G.H., Sanderson, R., Fields, K., Ballester, O.F. & Elfenbein, G.J. (1993) Cost-effectiveness of white cell-reduction filters in treatment of adult acute myelogenous leukemia. Transfusion, 33, 665-670.
5. Bilgin, Y.M., van de Watering, L.M., Eijsman, L., Versteegh, M.I., Brand, R., Van Oers, M.H. & Brand, A. (2004) Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery. Circulation, 109, 2755-2760.
6. Blumberg, N., Heal, J.M., Kirkley, S.A., DiPersio, J.F., Rapoport, A.P. & Rowe, J.M. (1995) Leukodepleted-ABO-identical blood components in the treatment of hematologic malignancies: a cost analysis. American Journal of Hematology, 48, 108-115.
7. Briggs, A.H., O'Brien, B.J. & Blackhouse, G. (2002) Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies. Annual Review of Public Health, 23, 377-401.
8. Briggs, A.H., Wonderling, D.E. & Mooney, C.Z. (1997) Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Economics, 6, 327-340.
9. Canadian Coordinating Office for Health Technology Assesment. (1998) Leukoreduction: the techniques used, their effectiveness and costs. Ottowa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA)
10. Finucane, M.L., Slovic, P. & Mertz, C.K. (2000) Public perception of the risk of blood transfusion. Transfusion, 40, 1017-1022.
11. Garner, J.S., Jarvis, W.R., Emori, T.G., Horan, T.C. & Hughes, J.M. (1988) CDC definitions for nosocomial infections, 1988. American Journal of Infection Control, 16, 128-140.
12. Jensen, L.S., Grunnet, N., Hanberg-Sorensen, F. & Jorgensen, J. (1995) Cost-effectiveness of blood transfusion and white cell reduction in elective colorectal surgery. Transfusion, 35, 719-722.
13. Knaus, W.A., Draper, E.A., Wagner, D.P. & Zimmerman, J.E. (1985) Prognosis in acute organ-system failure. Annals of Surgery, 202, 685-693.
14. Mark, D.B. & Hlatky, M.A. (2002) Medical economics and the assessment of value in cardiovascular medicine: Part II. Circulation, 106, 626-630.
15. Michel, B.C., van Hout, B.A. & Bonsel, G.J. (1994) Assessing the benefits of transplant services. Bailliere's Best Practice & Research. Clinical Gastroenterology, 8, 411-423.
16. Nightingale, S.D. (2001) Universal WBC reduction. Transfusion, 41, 1306-1309.
17. O'Brien, B.J., Gertsen, K., Willan, A.R. & Faulkner, L.A. (2002) Is there a kink in consumers' threshold value for cost-effectiveness in health care? Health Economics, 11, 175-180.
18. Oostenbrink, J.B., Koopmanschap, M.A. & Rutten, F.F. (2000) Handleiding voor Kosten, methoden en richtlijnprijzen voor economische evaluaties in de gezondheidzorg (Guidelines for Costing; in Dutch). Dicmen: College voor zorgverzeberingen.
19. Owens, D.K. (1998) Interpretation of cost-effectiveness analyses. Journal of General Internal Medicine, 13, 716-717.
20. Postma, M.J., van de Watering, L.M.G., de Vries, R., Versmoren, D., van Hulst, M., Tobi, H., van der Poel, C.L. & Brand, A. (2003) Cost-effectiveness of leucocyte depletion of red-cell transfusions for patients undergoing cardiac surgery. Vox Sanguinis, 84, 65-67.
21. Siegel, J.E., Weinstein, M.C., Russell, L.B. & Gold, M.R. (1996) Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA: The Journal of the American Medical Association, 276, 1339-1341.
22. Tengs, T.O., Adams, M.E., Pliskin, J.S., Safran, D.G., Siegel, J.E., Weinstein, M.C. & Graham, J.D. (1995) Five-hundred life-saving interventions and their cost-effectiveness. Risk Analysis, 15, 369-390.
23. Vamvakas, E.C. (2003) WBC-containing allogeneic blood transfusion and mortality: a meta-analysis of randomized controlled trials. Transfusion, 43, 963-973.
24. Vamvakas, E.C. (2004) White-blood-cell-containing allogeneic blood transfusion, postoperative infection and mortality: a meta-analysis of observational 'before-and-after' studies. Vox Sanguinis, 86, 111-119.
25. Vamvakas, E.C. & Blajchman, M.A. (2001) Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood, 97, 1180-1195.
26. Van Hulst, M., De Wolf, J.T., Staginnus, U., Ruitenberg, E.J. & Postma, M.J. (2002) Pharmaco-economics of blood transfusion safety: review of the available evidence. Vox Sanguinis, 83, 146-155.
27. Weinstein, M.C., Siegel, J.E., Gold, M.R., Kamlet, M.S. & Russell, L. B. (1996) Recommendations of the panel on cost-effectiveness in health and medicine. JAMA: The Journal of the American Medical Association, 276, 1253-1258.
28. Yusuf, S., Zucker, D., Peduzzi, P., Fisher, L.D., Takaro, T., Kennedy, J.W., Davis, K., Killip, T., Passamani, E. & Norris, R. (1994) Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet, 344, 563-570.